RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
JCR Pharmaceuticals Co

JCR Pharmaceuticals Co ROE 2024

JCR Pharmaceuticals Co ROE

0.07

JCR Pharmaceuticals Co Dividend yield

3.47 %

Ticker

4552.T

ISIN

JP3701000006

WKN

889627

In 2024, JCR Pharmaceuticals Co's return on equity (ROE) was 0.07, a -74.64% increase from the 0.29 ROE in the previous year.

JCR Pharmaceuticals Co Aktienanalyse

What does JCR Pharmaceuticals Co do?

JCR Pharmaceuticals Co. Ltd is a Japanese company founded in 1975. It is a global provider of biopharmaceutical products and services and is based in Ashiya, Japan. The company specializes in researching and developing therapies for rare genetic diseases, including the production of recombinant proteins and antibodies. It has three main business areas: biopharmaceuticals, diagnostics, and research services. JCR Pharmaceuticals works closely with universities, research institutions, and other companies to advance biotechnology research. It follows an ethical business model focused on integrity, transparency, openness, and fairness. The company has expanded into Europe and invested in a new research and development facility to enhance its presence and improve access to novel therapies for patients. Overall, JCR Pharmaceuticals has a strong position in the biotechnology and rare diseases field and has the potential to positively impact the lives of millions of people worldwide. JCR Pharmaceuticals Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding JCR Pharmaceuticals Co's Return on Equity (ROE)

JCR Pharmaceuticals Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing JCR Pharmaceuticals Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

JCR Pharmaceuticals Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in JCR Pharmaceuticals Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about JCR Pharmaceuticals Co Stock

What is the ROE (Return on Equity) of JCR Pharmaceuticals Co this year?

The ROE of JCR Pharmaceuticals Co this year is 0.07 undefined.

How has the Return on Equity (ROE) of JCR Pharmaceuticals Co developed compared to the previous year?

The ROE of JCR Pharmaceuticals Co has increased by -74.64% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of JCR Pharmaceuticals Co?

A high ROE indicates that JCR Pharmaceuticals Co generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of JCR Pharmaceuticals Co?

A low ROE can indicate that JCR Pharmaceuticals Co is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of JCR Pharmaceuticals Co affect the company?

A change in ROE (Return on Equity) of JCR Pharmaceuticals Co can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of JCR Pharmaceuticals Co?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of JCR Pharmaceuticals Co?

Some factors that can influence JCR Pharmaceuticals Co's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does JCR Pharmaceuticals Co pay?

Over the past 12 months, JCR Pharmaceuticals Co paid a dividend of 20 JPY . This corresponds to a dividend yield of about 3.47 %. For the coming 12 months, JCR Pharmaceuticals Co is expected to pay a dividend of 24.33 JPY.

What is the dividend yield of JCR Pharmaceuticals Co?

The current dividend yield of JCR Pharmaceuticals Co is 3.47 %.

When does JCR Pharmaceuticals Co pay dividends?

JCR Pharmaceuticals Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of JCR Pharmaceuticals Co?

JCR Pharmaceuticals Co paid dividends every year for the past 24 years.

What is the dividend of JCR Pharmaceuticals Co?

For the upcoming 12 months, dividends amounting to 24.33 JPY are expected. This corresponds to a dividend yield of 4.22 %.

In which sector is JCR Pharmaceuticals Co located?

JCR Pharmaceuticals Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von JCR Pharmaceuticals Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of JCR Pharmaceuticals Co from 6/1/2024 amounting to 10 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did JCR Pharmaceuticals Co pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of JCR Pharmaceuticals Co in the year 2023?

In the year 2023, JCR Pharmaceuticals Co distributed 20 JPY as dividends.

In which currency does JCR Pharmaceuticals Co pay out the dividend?

The dividends of JCR Pharmaceuticals Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von JCR Pharmaceuticals Co

Our stock analysis for JCR Pharmaceuticals Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of JCR Pharmaceuticals Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.